4.7 Article

The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma Progression

Journal

Publisher

MDPI
DOI: 10.3390/ijms23084187

Keywords

intrahepatic cholangiocarcinoma; NOTCH1; HuCCT1-xenograft mouse model; gene expression; microenvironment

Funding

  1. Italian Association of Cancer Research (AIRC) [18737]

Ask authors/readers for more resources

The study demonstrates that Crenigacestat effectively inhibits NOTCH1 and HES1, while not affecting tumor progression. The drug also triggers a strong immune response and blocks neovascularization in the tumor ecosystem without affecting fibrotic reactions.
Intrahepatic cholangiocarcinoma (iCCA) is a highly aggressive cancer with limited therapeutic options and short overall survival. iCCA is characterized by a strong desmoplastic reaction in the surrounding ecosystem that likely affects tumoral progression. Overexpression of the Notch pathway is implicated in iCCA development and progression. Our aim was to investigate the effectiveness of Crenigacestat, a selective inhibitor of NOTCH1 signaling, against the cross-talk between cancer cells and the surrounding ecosystem in an in vivo HuCCT1-xenograft model. In the present study, a transcriptomic analysis approach, validated by Western blotting and qRT-PCR on iCCA tumor masses treated with Crenigacestat, was used to study the molecular pathways responsive to drug treatment. Our results indicate that Crenigacestat significantly inhibited NOTCH1 and HES1, whereas tumor progression was not affected. In addition, the drug triggered a strong immune response and blocked neovascularization in the tumor ecosystem of the HuCCT1-xenograft model without affecting the occurrence of fibrotic reactions. Therefore, although these data need further investigation, our observations confirm that Crenigacestat selectively targets NOTCH1 and that the desmoplastic response in iCCA likely plays a key role in both drug effectiveness and tumor progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available